Mindfulness-based Intervention to Improve Psychological Resilience and Wellbeing on Medical Students (MBI-PMR)
Randomized Controlled Trial of Mindfulness-based Intervention to Improve Psychological Resilience and Wellbeing on Medical Students
Medical students often encounter significant stressors and challenges that, over time, can impact their academic performance and professional lives by diminishing psychological resilience and well-being, eventually leading to mental health issues and neurotic disorders. This is largely due to the demanding nature and responsibilities of medical school. Consequently, multiple studies have been conducted to identify prevention programs that can help students cope with these challenges. Although various behavioral therapy-based prevention and coping mechanisms have been proposed in the general population, few studies have specifically applied these programs to medical students, highlighting the need for further research in this group.
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Amani Alqarni, MBBS, MD
- Phone Number: +966591775751
- Email: Amqurni@iau.edu.sa
Study Locations
-
-
-
Dammam, Saudi Arabia, 34211
- Recruiting
- Imam Abdulrahman Bin Faisal University
-
Contact:
- Mohammed Aljumaan
- Phone Number: 00966133333
- Email: majumaan@iau.edu.sa
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Undergraduate medical students from 2nd year to 6th year at Imam Abdulrahman bin Faisal University
Description
Inclusion Criteria: Undergraduate medical students from 2nd year to 6th year at Imam Abdulrahman bin Faisal University -
Exclusion Criteria: students who do not meet the academic level limit, students who currently having a freeze year, or students having an incomplete interview assessment
-
Study Plan
How is the study designed?
Design Details
- Observational Models: CASE_CONTROL
- Time Perspectives: PROSPECTIVE
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Psychological Wellbeing
Time Frame: 8 weeks
|
Psychological wellbeing will be assessed using the World Health Organization-5 Wellbeing Index. Total scores range from 0 to 25 and standardized to be out of 100, with higher scores reflecting better psychological wellbeing. Change will be calculated as the post-intervention score minus the baseline score. (score on scale: All the time (5) -at no time (0) All the time reflects the highest score) |
8 weeks
|
|
Change in Psychological Resilience
Time Frame: 8 weeks
|
Psychological resilience will be assessed using the Connor Davidson resilience scale. Total scores range from 0 to 100, with higher scores indicating greater psychological resilience. Change will be calculated as the post-intervention score minus the baseline score. (score on scale: Not true at all (0) - true nearly all the time (4) True nearly all the time is the maximum score while not true at all is the minimum) |
8 weeks
|
|
Change in State Anxiety
Time Frame: 8 weeks
|
State anxiety will be assessed using the state anxiety subscale of the state trait anxiety inventory scale, which measures anxiety at the time of assessment. Subscale scores range from 20 to 80 following the reverse scoring of applicable items, with higher scores indicating greater state anxiety. Change will be calculated as the post-intervention score minus the baseline score. (Score on scale: not at all (1) - very much so (4) Not at all is the minimum while very much so is the maximum) |
8 weeks
|
|
Change in Trait Anxiety
Time Frame: 8 weeks
|
Trait anxiety will be assessed using the trait anxiety subscale of the state trait anxiety inventory scale, which measures the general tendency to experience anxiety. Subscale scores range from 20 to 80 following the reverse scoring of applicable items, with higher scores indicating greater trait anxiety. Change will be calculated as the post-intervention score minus the baseline score. (score on scale: Almost never (1) - almost always(4) almost never is the minimum while almost always is the maximum) |
8 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- IRB-2025-01-0912
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.